Gitanjali V Patel1, Eduardo Pascual Van Sant1, Bret Taback2, Richard Ha1. 1. 1 Department of Breast Imaging, Columbia University Medical Center, 161 Fort Washington Ave, 10th Fl, New York, NY 10032. 2. 2 Department of Surgery, Columbia University Medical Center, New York, NY.
Abstract
OBJECTIVE: The purpose of this article is to report on a study conducted to determine whether the lesions in patients with what is deemed to be low-risk ductal carcinoma in situ (DCIS) selected for two large clinical trials are in fact low-risk lesions. CONCLUSION: A retrospective review was conducted to determine whether the eligibility criteria of the two trials are predictive that DCIS is low risk. More than 20% of lesions are upgraded to invasive carcinoma in patients with low-risk DCIS as defined in two large clinical trials. More accurate methods are needed to determine whether patients with a diagnosis of low-grade DCIS can be treated less aggressively.
OBJECTIVE: The purpose of this article is to report on a study conducted to determine whether the lesions in patients with what is deemed to be low-risk ductal carcinoma in situ (DCIS) selected for two large clinical trials are in fact low-risk lesions. CONCLUSION: A retrospective review was conducted to determine whether the eligibility criteria of the two trials are predictive that DCIS is low risk. More than 20% of lesions are upgraded to invasive carcinoma in patients with low-risk DCIS as defined in two large clinical trials. More accurate methods are needed to determine whether patients with a diagnosis of low-grade DCIS can be treated less aggressively.
Entities:
Keywords:
breast cancer; ductal carcinoma in situ; invasive breast carcinoma
Authors: Simukayi Mutasa; Peter Chang; Eduardo P Van Sant; John Nemer; Michael Liu; Jenika Karcich; Gita Patel; Sachin Jambawalikar; Richard Ha Journal: Acad Radiol Date: 2019-09-14 Impact factor: 3.173
Authors: Mieke R Van Bockstal; Marie C Agahozo; Linetta B Koppert; Carolien H M van Deurzen Journal: Int J Cancer Date: 2019-05-08 Impact factor: 7.396
Authors: Fernando A Angarita; Robert Brumer; Matthew Castelo; Nestor F Esnaola; Stephen B Edge; Kazuaki Takabe Journal: Cancers (Basel) Date: 2022-09-20 Impact factor: 6.575